Orthoscan
Private Company
Total funding raised: $14M
Overview
Orthoscan is a private, commercial-stage medical device company focused on the mobile C-arm imaging market, primarily for orthopedics. The company has a portfolio of products, including the TAU series and Versa systems, which emphasize reduced radiation dose, portability, and flat-panel technology. It operates a full business model encompassing manufacturing, sales, service, and financing, targeting surgical centers, clinics, and hospitals. Orthoscan's strategy is built on direct customer relationships, nationwide service support, and a focus on innovative imaging solutions for procedural guidance.
Technology Platform
Mobile C-arm fluoroscopic imaging systems with focus on mini C-arms, flat-panel digital detectors, and dose optimization technology for surgical and clinical guidance.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Orthoscan competes in a crowded market dominated by global giants like Siemens, GE, and Philips, as well as other focused players like Ziehm Imaging, Hologic, and Shimadzu. Its strategy is to compete on specialization in orthopedic imaging, dose reduction, portability, and customer service rather than attempting to match the full portfolio of the largest competitors.